Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Does the Forecast Indicate for the Travel Vaccines Market From 2025 to 2029?

In the past few years, there has been substantial growth in the microbial API market size. This market is anticipated to expand from $62.9 billion in 2024 to $67.52 billion in 2025, displaying a compound annual growth rate (CAGR) of 7.4%. The growth during the historical period can be credited to factors such as enhanced drug demand, government emphasis on healthcare and pharmaceuticals, a rising imperative to meet nutritional needs, the quest for sustainability and cost-effectiveness, and an uptick in the demand for biological drugs.

The market size of the microbial API is set to witness considerable expansion in the upcoming years, escalating to “$89.86 billion by 2029 with a compounded annual growth rate (CAGR) of 7.4%. The forecasted growth is primarily due to its growing uses in the pharmaceutical sector, an alarming increase in chronic diseases, a surge in healthcare spending, greater accessibility to sophisticated medical facilities, and an increase in infections and antibiotic resistance. The aforementioned period will also see significant trends such as modernization in fermentation and downstream processing technologies, breakthroughs in microbial fermentation technologies, investments funnelled towards bioprocessing, progress in molecular and synthetic biology, and advancements in product offerings.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15861&type=smp

What Elements Are Contributing To Growth In The Travel Vaccines Market?

The surge in travel and tourism is predicted to stimulate the travel vaccine market’s growth in the foreseeable future. Travel and tourism involve the transfer of people or objects, utilizing various modes of transport such as trains, boats, airplanes, and other vehicles across different far-flung geographic locations. Travel vaccines serve an integral role in protecting tourists and travelers, ensuring their health and safety during their international travels. To exemplify, the United Nations World Tourism Organization (UNWTO), an intergovernmental organization headquartered in Spain and dedicated to promoting tourism, reported in January 2023 that the number of tourists traveling abroad in 2022 exceeded 900 million. This figure is twice the number in 2021 and a 63% increase from before the pandemic. As a result, the escalating travel and tourism trend fuels the expansion of the travel vaccine market.

The microbial api market covered in this report is segmented –

1) By Type: Antibody, Peptide, Protein, Small Molecule, Vaccine

2) By Host: Mammalian, Bacterial, Fungal

3) By Site: In-House, Outsourced

4) By Molecule: Innovative, Generic

5) By End-Use: Pharmaceutical Companies, Biopharmaceutical Companies, Other End-Uses

Subsegments:

1) By Antibody: Monoclonal Antibodies, Polyclonal Antibodies

2) By Peptide: Therapeutic Peptides, Diagnostic Peptides

3) By Protein: Recombinant Proteins, Native Proteins

4) By Small Molecule: Antibiotics, Antifungals, Antivirals

5) By Vaccine: Bacterial Vaccines, Viral Vaccines

What Trends Are Currently Influencing Growth In The Travel Vaccines Market?

Leading firms in the microbial API market are innovating novel API goods, such as excipients, to increase the effectiveness of drugs, fortify formulation stability, and comply with regulatory norms. Excipients are materials incorporated with the primary ingredient of a drug to serve diverse objectives like stabilization, enhancing formulations, augmenting therapeutic characteristics, and assisting in production. For instance, Clariant, a chemical corporation based in Switzerland, unveiled a new assortment of excipients in October 2023 with the intent of enhancing the stability and solubility of active pharmaceutical ingredients (APIs). This enhancement includes three novel VitiPure excipients, specifically devised to tackle obstacles in API delivery and bioavailability, and to cater to various dosage requirements including oral, topical, and parenteral administration. The objective of these excipients is to bolster the pharmaceutical industry by supplying efficient carrier systems for drug delivery, particularly for delicate medications such as mRNA vaccines and biologics.

Who Are The Key Contributors To Growth In The Travel Vaccines Market?

Major companies operating in the microbial API market are BASF SE, Merck& Co Inc., AbbVie Inc., Bayer AG, Sanofi S.A., AstraZeneca Plc, GlaxoSmithKline Plc, Eli Lilly And Company, Boehringer Ingelheim GmbH, Amgen Inc., Evonik Industries AG, TEVA Pharmaceutical industries Ltd., Lonza Group AG, Catalent Inc., CSPC Pharmaceutical Group Ltd., Patheon, Dr. Reddy’s Laboratories Ltd., Siegfried Ltd., Recipharm AB, Shandong Lukang Pharmaceutical Co. Ltd., Tianjin Tianyao Pharmaceuticals Co. Ltd., Xellia Pharmaceuticals, Kolon Life Science Inc., Royal DSM NV, Henan Topfond Pharmaceutical Co. Ltd.

https://www.thebusinessresearchcompany.com/report/microbial-api-global-market-report

Which Region Is Projected To Lead The Travel Vaccines Market By 2025?

Asia-Pacific was the largest region in the microbial API market in 2024. The regions covered in the microbial API market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15861&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model